Contralateral breast cancer risk is influenced by the age at onset in BRCA1-associated breast cancer

BRCA1/2 mutation carriers diagnosed with breast cancer have a strongly elev ated life-time risk of developing a contralateral tumour. We studied the co ntralateral breast cancer risk in 164 patients from 83 families with a prov en BRCA1 mutation in relation to the age at diagnosis of the first primary breast cancer. In the actuarial outcomes after 10 years' follow-up, 40% of the 124 BRCA1-patients diagnosed with breast cancer < 50 years had develope d contralateral breast cancer, vs 12% of the 40 patients > 50 years at firs t diagnosis (P-logrank = 0.02). These data suggest that age at diagnosis of the first tumour should be taken into account when prophylactic mastectomy in BRCA1-patients is considered. (C) 2000 Cancer Research Campaign.